94 related articles for article (PubMed ID: 23422487)
21. Immunohistochemical study of the inflammatory infiltrate associated with equine squamous cell carcinoma.
Pérez J; Mozos E; Martín MP; Day MJ
J Comp Pathol; 1999 Nov; 121(4):385-97. PubMed ID: 10542127
[TBL] [Abstract][Full Text] [Related]
22. Phagocytosis by dendritic cells rather than MHC IIhigh macrophages is associated with skin tumour regression.
Byrne SN; Halliday GM
Int J Cancer; 2003 Sep; 106(5):736-44. PubMed ID: 12866034
[TBL] [Abstract][Full Text] [Related]
23. Cellular immunophenotyping of exfoliative dermatitis in canine leishmaniosis (Leishmania infantum).
Papadogiannakis EI; Koutinas AF; Saridomichelakis MN; Vlemmas J; Lekkas S; Karameris A; Fytianou A
Vet Immunol Immunopathol; 2005 Apr; 104(3-4):227-37. PubMed ID: 15734543
[TBL] [Abstract][Full Text] [Related]
24. Mitosis and apoptosis in canine cutaneous histiocytoma and transmissible venereal tumour.
Guvenc T; Haligur M; Orman MN; Haziroglu R
Acta Vet Hung; 2002; 50(3):315-21. PubMed ID: 12237973
[TBL] [Abstract][Full Text] [Related]
25. Pro-IL-16 is associated with MHC class II-mediated negative regulation of mouse resting B cell activation through MAP kinases, NF-κB and Skp2-dependent p27kip regulation.
Yang HY; Kim J; Kim SH; Choe CH; Jang YS
Scand J Immunol; 2013 Mar; 77(3):177-86. PubMed ID: 23297678
[TBL] [Abstract][Full Text] [Related]
26. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
[TBL] [Abstract][Full Text] [Related]
27. Regression of canine cutaneous histiocytoma is associated with an orchestrated expression of matrix metalloproteinases.
Puff C; Risha E; Baumgärtner W
J Comp Pathol; 2013; 149(2-3):208-15. PubMed ID: 23582970
[TBL] [Abstract][Full Text] [Related]
28. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
29. Morphologic and biologic characteristics of the canine cutaneous histiocytoma.
Taylor DO; Dorn CR; Luis OH
Cancer Res; 1969 Jan; 29(1):83-92. PubMed ID: 4303447
[No Abstract] [Full Text] [Related]
30. Modulation by canine interferon-gamma of major histocompatibility complex and tumor-associated antigen expression in canine mammary tumor and melanoma cell lines.
Whitley EM; Bird AC; Zucker KE; Wolfe LG
Anticancer Res; 1995; 15(3):923-9. PubMed ID: 7645983
[TBL] [Abstract][Full Text] [Related]
31. Immunobiology of a spontaneously regressive tumor, the canine transmissible venereal sarcoma (review).
Yang TJ
Anticancer Res; 1988; 8(1):93-5. PubMed ID: 3282476
[TBL] [Abstract][Full Text] [Related]
32. Generalized cutaneous histiocytoma in a dog (a case report).
Garma-Avina A; Fromer E
Vet Med Small Anim Clin; 1979 Sep; 74(9):1269-70. PubMed ID: 229617
[No Abstract] [Full Text] [Related]
33. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous histiocytoma in a goat.
Roth L; Perdrizet J
Cornell Vet; 1985 Apr; 75(2):303-6. PubMed ID: 2985332
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of major histocompatibility complex class II compartments in cortical thymic epithelial cells.
Arudchelvan Y; Nishimura Y; Tokuda N; Sawada T; Ueyama Y; Fukumoto T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):798-806. PubMed ID: 12923890
[TBL] [Abstract][Full Text] [Related]
36. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous histiocytomas of dogs.
Howard EB; Nielsen SW
Natl Cancer Inst Monogr; 1969 Aug; 32():321-7. PubMed ID: 4310776
[No Abstract] [Full Text] [Related]
38. An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats.
Vanherberghen M; Day MJ; Delvaux F; Gabriel A; Clercx C; Peeters D
J Comp Pathol; 2009 Jul; 141(1):17-26. PubMed ID: 19362315
[TBL] [Abstract][Full Text] [Related]
39. Traffic of major histocompatibility complex class II molecules in rabbit lacrimal gland acinar cells.
Mircheff AK; Gierow JP; Wood RL
Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3943-51. PubMed ID: 7928193
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
